LASA

Lasa Supergenerics Share Price

₹28.53 -0.59 (-2.03%)

05 Nov, 2024 22:09

SIP TrendupStart SIP in LASA

Start SIP

Performance

  • Low
  • ₹29
  • High
  • ₹29
  • 52 Week Low
  • ₹19
  • 52 Week High
  • ₹41
  • Open Price₹0
  • Previous Close₹29
  • Volume16,318

Investment Returns

  • Over 1 Month + 6.61%
  • Over 3 Month + 19.32%
  • Over 6 Month + 15.51%
  • Over 1 Year + 15.27%
SIP Lightning

Smart Investing Starts Here Start SIP with Lasa Supergenerics for Steady Growth!

Lasa Supergenerics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -7.3
  • PEG Ratio
  • -0.2
  • Market Cap Cr
  • 143
  • P/B Ratio
  • 1.5
  • Average True Range
  • 1.68
  • EPS
  • -2.8
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.41
  • RSI
  • 57.55
  • MFI
  • 43.8

Lasa Supergenerics Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations30.8422.8226.6624.3030.56
Total Income From Operations30.8422.8226.6624.3030.56
P/L Before Interest, Excpt. Items & Tax-0.99-6.63-1.62-1.551.40
P/L Before Exceptional Items & Tax-1.86-7.19-2.06-2.111.03
P/L After Tax from Ordinary Activities-2.73-15.30-1.46-0.02-4.95
Net Profit/Loss For the Period-2.73-15.30-1.46-0.02-4.95
IndicatorMar 24Mar 23
Revenue From Operations [Gross]104.34129.57
Revenue From Operations [Net]104.34129.57
Total Operating Revenues104.34129.57
Total Revenue104.43131.37
Total Expenses114.77153.74
Profit/Loss Before Tax-19.11-42.27
Profit/Loss For The Period-21.73-38.62
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity2.14-17.30
Net Cash Used In Investing Activity-0.4011.19
Net Cash Used in Finance Activity-1.93-4.16
Net Inc/Dec In Cash And Equivalent-0.19-10.27
Cash And Equivalent End Of Year0.610.80
IndicatorMar 24Mar 23
Total Share Capital50.1050.10
Total Non-Current Liabilities5.322.84
Total Current Liabilities48.8742.73
Total Capital And Liabilities150.87163.86
Total Non-Current Assets112.98124.63
Total Current Assets37.8939.22
Total Assets150.87163.86
Indicator20242023
EBIT Margin (%)-8.05-14.05
Return On Capital Employed (%)-8.24-15.03
Return On Equity (%)-22.47-32.65
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)19.3023.61
Indicator20242023
EBIT Margin (%)-8.05-14.05
Return On Capital Employed (%)-8.24-15.03
Return On Equity (%)-22.47-32.65
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)19.3023.61

Lasa Supergenerics Technicals

EMA & SMA

Current Price
₹28.53
-0.59 (-2.03%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹27.01
  • 50 Day
  • ₹27.12
  • 100 Day
  • ₹26.74
  • 200 Day
  • ₹26.61

Resistance and Support

28.53 Pivot Speed
  • R3 28.53
  • R2 28.53
  • R1 28.53
  • S1 28.53
  • S2 28.53
  • S3 28.53

Is Lasa Supergenerics Worth Buying?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Lasa Supergenerics has an operating revenue of Rs. 104.61 Cr. on a trailing 12-month basis. An annual revenue de-growth of -21% needs improvement, Pre-tax margin of -18% needs improvement, ROE of -22% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 13% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 25 which is a POOR score indicating inconsistency in earnings, a RS Rating of 55 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 20 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Lasa Supergenerics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-08-14 Quarterly Results
2024-05-30 Audited Results
2024-02-13 Quarterly Results
2023-11-10 Quarterly Results
2023-08-14 Quarterly Results

Lasa Supergenerics F&O

Lasa Supergenerics Shareholding Pattern

53.65%
0.01%
34.07%
12.27%
  • NSE Symbol
  • LASA
  • BSE Symbol
  • 540702
  • Chairman & Managing Director
  • Dr. Omkar Pravin Herlekar
  • ISIN
  • INE670X01014

Lasa Supergenerics FAQs

Lasa Supergenerics share price is ₹28 As on 05 November, 2024 | 21:55

The Market Cap of Lasa Supergenerics is ₹142.9 Cr As on 05 November, 2024 | 21:55

The P/E ratio of Lasa Supergenerics is -7.3 As on 05 November, 2024 | 21:55

The PB ratio of Lasa Supergenerics is 1.5 As on 05 November, 2024 | 21:55

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form